Utilization of quantitative in vivo pharmacology approaches to assess combination effects of everolimus and irinotecan in mouse xenograft models of colorectal cancer. par Erica L Bradshaw-Pierce, Todd M Pitts, Gillian Kulikowski, Heather Selby, Andrea L Merz, Daniel L Gustafson, Natalie J Serkova, S Gail Eckhardt, Colin D Weekes

Accéder au texte intégral

Stromal Cell-Derived Factor 1α Mediates Resistance to mTOR-Directed Therapy in Pancreatic Cancer par Colin D. Weekes, Dongweon Song, John Arcaroli, Lora A. Wilson, Belen Rubio-Viqueira, George Cusatis, Elizabeth Garrett-Mayer, Wells A. Messersmith, Robert A. Winn, Manuel Hidalgo

Accéder au texte intégral

Leveraging patient‐reported outcomes (PROs) in patients with pancreatic cancer: The Pancreatic Cancer Action Network (PanCAN) online patient registry experience par Arjun Gupta, Omar Khalid, Cassadie Moravek, Anica Lamkin, Lynn M. Matrisian, Sudheer Doss, Crystal S. Denlinger, Andrew L. Coveler, Colin D. Weekes, Eric J. Roeland, Andrew E. Hendifar, Ryan D. Nipp

Accéder au texte intégral

The efficacy and safety of cardio-protective therapy in patients with 5-FU (Fluorouracil)-associated coronary vasospasm. par Amna Zafar, Zsofia D Drobni, Matthew Lei, Carlos A Gongora, Thiago Quinaglia, Uvette Y Lou, Ramya Mosarla, Sean P Murphy, Maeve Jones-O'Connor, Ali Mahmood, Sarah Hartmann, Hannah K Gilman, Colin D Weekes, Ryan Nipp, John R Clark, Jeffrey W Clark, Lawrence S Blaszkowsky, Erica Tavares, Tomas G Neilan

Accéder au texte intégral